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Chapter 1: Introduction
1.1 Mitochondria
Mitochondria, which arose over 2 billion years ago, are essential organelles for
eukaryotic development and energy production (1). Mitochondria are membranecontaining organelles within the cytoplasm that generate the cellular energy needed for
eukaryotic biochemical reactions to occur. Mitochondria are unique organelles due to their
double membrane system, an inner mitochondrial membrane (IMM) and an outer
mitochondrial membrane (OMM). The OMM faces the cytosol, where it maintains a barrier
between the cytosol and the intermembrane space (IMS). Additionally, the IMM has a
unique curved structure created by its cristae folds, allowing the membrane to be
impermeable to most molecules and ions, which is a very important feature for respiration
(2,3).
Another unique feature of mitochondria is that they contain an exclusive
phospholipid known as Cardiolipin (CL). CL is embedded within the IMM and has
important functions in the regulation of many types of mitochondrial proteins such as
carrier proteins and kinases (4). CL is also essential for cristae organization and other
mitochondrial contact sites that are important for mitochondrial stability (4,5).
Canonically, cellular energy is produced from the mitochondria in the form of
adenosine triphosphate (ATP). This form of energy is produced from a series of redox
reactions in a coupling process known as oxidative phosphorylation (OxPhos). During
OxPhos electrons are continuously shuttled through a series of protein complexes within
the electrons transport chain (ETC). These protein complexes are embedded within the
IMM and pump protons into the IMS creating an electrochemical gradient across the
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membrane (6). The complexes that pump protons into the IMS are Complexes I, III, and
IV also known as NADH dehydrogenase, cytochrome c reductase, and cytochrome c
oxidase (COX), respectively. The generation of ATP is fueled by a two-part system
creating a charge gradient known as the mitochondrial proton motive force. The proton
motive force comprises of the mitochondrial membrane potential (ΔΨm) and the ΔpH
(6,7). During cellular respiration, the electrons from NADH and FADH2 are shuttled into
the ETC through complex I and complex II also known as succinate dehydrogenase. It
should be noted that complex II does not contribute to the mitochondrial proton motive
force nor does it act as a proton pump. However, the Citric Acid Cycle and complex II are
linked to the ETC by an oxidation-reduction reaction occurring between succinate and
FAD where the flavin molecule is reduced to FADH2. From the TCA cycle, electrons from
NADH are passed to complex I of the ETC. From there, the pair of electrons is transferred
to ubiquinone where it acts as a shuttling molecule from Complex I/II to Complex III of the
ETC. Once the electrons reach complex III, the electrons undergo a two-step process in
complex III known as the Q-cycle ultimately satisfying the oxidation-reduction forms of
ubiquinone (8,9). Cytochrome c (Cytc) is then deployed where it acts as a single electron
carrier between complex III and complex IV of the ETC where the electrons are then
delivered to the final electron acceptor, oxygen. The lumped protons taken up by COX
from the matrix, along with the chemical protons, maintain and stabilize the
electrochemical gradient, thereby contributing to the proton motive force. (10,11). ATP
synthase is able to use the proton motive force that is created through the ETC to
generate ATP by adding a phosphate group to ADP (7,12,13).
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Due to the uncontrollable and fickle nature of electrons, the process of electron shuffling
has produced pathological consequences such as the generation of reactive oxygen
species (ROS). However, it is important to note that under normal conditions, ROS
production is small, but massive ROS production occurs in certain disease pathologies.
ROS can be generated at complex I and III of the ETC and it has been shown that it
requires a hyperpolarization of the ΔΨm (14,15). During ΔΨm hyperpolarization, the
potential exceeds its normal range of 80-120 mV leading to damaged mitochondria and
an exponential increase of ROS production (16). It has been examined that ROS damage
can ultimately lead to cell death allowing superoxide and H2O2 to compromise the integrity
of mitochondrial DNA and other macromolecules (17,18).

1.2 Cytochrome c (Cytc)
Cytc is a highly conserved, globular, nuclear encoded mitochondrial protein (12.4-kDa,
104 amino acid residues) that contains a covalently attached heme group essential for its
catalytic functions. It regulates multiple processes that make life and death decisions in
cells. Cytc has an isoelectric point of 9.6 where it is important for aerobic energy
production (19). In a study analyzing metabolic shifts, Cytc knockout mice died during
mid-gestation when cellular energy production switched from glycolysis to OxPhos (20).
The outcome of death is seen with the mice during mid-gestation due to only 5% of their
energy being relied on glycolysis during its developmental stage. Following an 11-day
gestation period, their energy source is switched to OxPhos (21).
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Encoded by the CYC gene, Cytc synthesis occurs in the cytoplasm where it becomes an
apoprotein and once it is translocated into the mitochondria it covalently attaches to the
heme prosthetic group at cysteines 14 and 17 via a thioester bond (19,22,23).
Canonically, Cytc is found within the IMS and acts as a single electron carrier from
complex III to complex IV of the ETC. In addition to sustaining cellular life, it also promotes
cell death by acting as a component of the apoptosome. Both of these cellular life and
death processes will be given an in-depth analysis below. Given the importance of these
functions, it has been hypothesized that Cytc is regulated through cell signaling
mechanisms such as posttranslational modifications (PTMs), allosteric regulation, and
tissue specific isoform regulation. Therefore, thoughtful analysis will be done on each of
these regulatory features (24-28).

1.3 Cytochrome c structure
The first structure of Cytc was solved from horse heart Cytc using X-ray crystallography
at a resolution of 4Å (29). With improving technologies and experimental designs, it was
later resolved at 1.94Å giving a detailed view of Cytc’s atomic structure (30). It was
determined that the covalently attached heme group, the catalytic site of the protein, was
attached to cysteines 14 and 17 via thioester linkages. The heme iron has a
hexacoordinate configuration within Cytc due to the 4 heme nitrogen atoms and the Met80
and His18 ligands as shown in Figure 1. The hexacoordinate state of the heme group
from the Met80 - iron bond causes a weak 695 nm absorption peak when Cytc is oxidized.
This accounts for Cytc’s overall protein stability and precise structural integrity (19). The
surrounding environment of the heme group is hydrophobic due to the aromatic side

5
chains present within the protein giving Cytc a high redox potential of 260 mV. The large
redox potential demonstrates the importance of the hexacoordinate iron to aid Cytc in
acquiring electrons in the ETC (31). Cytc displays characteristic alpha, beta, and gamma
peaks at 550, 521 and 408 nm, respectively, in its reduced state. The preciseness of the
spectrum also demonstrates Cytc’s structural integrity. The reduced absorption spectrum
is shown in Figure 2.

Figure 1. Crystallographic structure of native Cytc based on the crystal structure as
described in PDB entry 1HRC (30). The structure demonstrates the Met80 and His18
ligands bound to the heme prosthetic group via thioester linkages (32).
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Figure 2. Demonstrated above is the absorbance spectrum of reduced and oxidized WT
Cytc from horse heart (33). The dashed line represents the oxidized spectrum while the
solid line represents the reduced spectrum. The 408 nm gamma peak is the characteristic
heme group peak. The alpha and beta bands are characteristic absorption peaks shown
at 550 and 521 nm, respectively.

1.4 Cytochrome c functions
Cytc serves as a cellular life and death decision making molecule. Therefore, it has
essential functions that promote each of these capabilities. A thorough analysis will be
given to some of these functions below.
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1.4.1 Pro-cellular life role of Cytochrome c in mitochondrial respiration
The overall goal of OxPhos is to generate energy in the form of ATP. While ATP
generation also takes place during glycolysis, a majority of ATP is produced in the ETC,
located in the IMM. During cellular respiration, the electrons from NADH and FADH2 are
shuttled into the ETC through Complex I and Complex II and allows protons to be pumped
at complexes I, III, and IV, generating a proton gradient across the membrane known as
the mitochondrial proton motive force. Cytc plays an important role as an electron carrier,
transferring a single electron from complex III (bc1 complex) to complex IV (COX). Four
electron transfers from complex III to complex IV are required to generate water from the
final electron acceptor, oxygen, and together with the 4 protons taken up from the
mitochondrial matrix contribute to the generation of the membrane potential (ΔΨm). ΔΨm
is used by ATP synthase to promote the final step of OxPhos where ATP is generated
from ADP and phosphate (19). The electron transfer from Cytc to complex IV is the
proposed rate-limiting step of the ETC (34-37).

1.4.2 Cytochrome c’s role in apoptosis
Cytc plays a key role in the intrinsic apoptosis pathway. During apoptosis, intracellular
stress signals induce the release of Cytc from the IMS into the cytosol. Some of the stress
signals include, but are not limited to, oxidative stress and ROS generation, as described
previously. A pathological example of this is ischemia/reperfusion injury. In the intrinsic
pathway of apoptosis, the cellular stress activates the BH3-only proteins, which are
proteins that control mitochondrial apoptosis by promoting either pro-survival or proapoptotic factors (38). Once activated, members of the Bcl-2 family proteins, Bax and Bak
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interact. Canonically, Bax is localized in the cytosol, while Bak is embedded in the lipid
bilayer of the OMM. However, during apoptosis, Bax translocates to the OMM where it
interacts with Bak and causes Bax/Bak oligomerization forming pores that make the OMM
permeable. Once permeabilization of the OMM occurs, Cytc is released through these
pores into the cytosol and binds to apoptotic protease-activating factor 1 (Apaf-1).
Sequentially, this causes Cytc to displace the CARD domain of Apaf-1, forming the
apoptosome, a large heptameric protein. The apoptosome then activates caspase-9,
which acts as a cleavage factor of capase-3 thereby initiating apoptosis. The cleavage of
caspse-3 is considered to be the committed step in apoptosis (19,39,40).

1.4.3 Cytochrome c’s function as a ROS scavenger and producer
ROS generation is a direct consequence of the ETC. Major ROS species are superoxide
(O2•–), hydrogen peroxide (H2O2), and hydroxyl radicals (•OH) (19). The process of
electron shuttling in the ETC leads to pathological consequences such as the generation
of ROS. ROS can be generated at complexes I and III of the ETC. This is due to multiple
side reactions that take place at redox intermediates during electron transfer (41,42). The
ROS produced in the mitochondrial matrix side is generated from complex I of the ETC,
while at complex III ROS is generated into the IMS (43-45). ROS production impairs many
proteins and can also cause irreversible cellular DNA damage, ultimately leading to cell
death (45,46).
Most ROS are generated in the mitochondria. Cytc can also function as a ROS
scavenger. Cytc does this by accepting an electron from O2•–, thereby oxidizing
superoxide back to an energetically stable oxygen molecule (47). Additionally, it can be
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used as a hydrogen peroxide scavenger, where Cytc reduces hydrogen peroxide to water
(48,49). Therefore, Cytc has a very important function to impede the production of ROS
as an essential antioxidant of the cell.

1.4.4 Cytochrome c and the oxidation of cardiolipin
The predominant and unique lipid found exclusively embedded within the IMM is
cardiolipin (CL). One of the pro-apoptotic functions of Cytc is its cardiolipin peroxidase
activity. The proposed mechanism of Cytc’s release occurs during an initial interaction
with CL and tbid, a pro-apoptotic protein. This promotes Cytc binding to CL. When Cytc
binding to CL occurs, permeabilization of the OMM follows allowing free Cytc to be
released from the IMS into the cytosol, activating apoptosis (50). These interactions
ultimately activate Cytc as a peroxidase. CL comprises approximately 25% of the IMM
lipids and structurally contains 4-alkly groups containing an unsaturated 18-carbon chain
(24,25). CL is able to give stability to the IMM under normal conditions, thereby promoting
respiration. It has been shown that approximately 15 to 20% of Cytc is bound to CL, while
the rest reside within the IMS (51).
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1.5 Regulation of Cytochrome c
1.5.1 Allosteric regulation
Cytc and COX are the key players of the terminal step of the ETC. The reaction between
Cytc and COX is the proposed irreversible rate-limiting step of the ETC. Given this very
important function, both these proteins are tightly regulated through allosteric interactors,
tissue specific isoforms, and PTMs such as phosphorylation. Allosterically, ATP binds to
Cytc causing the ETC activity to be downregulated, most likely due to a feedback
inhibition mechanism attributed from an excess of ATP. ATP is able to bind to Cytc at
multiple sites: Glu62, Lys88, and Arg91 (52).

1.5.2 Regulation through tissue-specific isoforms
There are two isoforms of Cytc that have been expressed in rodents: the first being
somatic Cytc (S-Cytc), which is expressed in all tissues, and testis-specific isoforms (TCytc) expressed in germinal epithelial cells. It was reported that 86% of the T-Cytc is
evolutionary conserved with respect to S-Cytc. However, a decrease in expression was
seen in the testicular germ cells. In the process of maturation of spermatogenesis, the TCytc becomes predominant (48,53,54). The T-Cytc also plays important role in ROS
scavenging in the sperm in that the T-Cytc is able to readily eliminate increased hydrogen
peroxide thus preventing the damage of sperm resulted from ROS generation.
Additionally, apoptotic activity was dramatically increased with T-Cytc form, most likely
due to eliminating dysfunctional sperm and protecting healthy DNA to being completely
transmissible to the offspring. During primate evolution, human genomic region syntenic
to the testes-isoform in rodents has become a non-transcribed pseudogene (55,56).
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1.5.3 Regulation of Cytochrome c via post-translational modifications
Post-translational modifications (PTMs) are among the most important regulatory
mechanisms of proteins and cellular pathways. Currently, Cytc is able to be modified
through various types of modifications such as phosphorylation, acetylation, methylation,
nitrosylation, nitration, and sulfoxidation (57). Kalpage et al. 2019, described an in-depth
analysis of these important regulatory modifications. Our lab has mainly focused on
phosphorylation as a regulatory mechanism of Cytc. The Hüttemann lab has so far fully
characterized and mapped multiple phosphorylation sites of Cytc: Tyr48, Tyr97, Thr28,
Ser47, and Thr58. An in-depth and thoughtful analysis will be given to each
phosphorylation site in the following chapter. Interestingly, our lab was the first to report
that Cytc regulation takes place in a tissue-specific manner to meet the needs of various
tissues. It has been demonstrated by our lab that the ETC is continuously regulated by
phosphorylation,

specifically

through

controlled

respiration

that

prevents

hyperpolarization of the mitochondrial membrane potential. The prevention of
hyperpolarization contributes to lowered ROS production and inhibition of apoptosis. The
working hypothesis of our lab suggests that cell signaling mechanisms, such as through
Cytc phosphorylation, controls the ETC and determines the magnitude of the membrane
potential. We propose that phosphorylation helps maintain the membrane potential within
a healthy intermediate range that doesn’t lead to energy depletion or ROS production. As
shown in Figure 3, when membrane potential is low, this results in energy depletion which
is seen during pathological ischemic states, for example. However, when the
mitochondrial membrane potential is high, there will be an exponential increase in ROS
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production. Therefore, it is very important that the mitochondrial membrane potential is
balanced.

Figure 3. Demonstrated above is the proposed working hypothesis, where
phosphorylation of Cytc regulates electron flux within the ETC, ΔΨm, and ROS generation
(57).
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Chapter 2: Functional Effects of Threonine 49 Phosphorylation of Cytochrome c
The objective of the proposed research is to determine the role of T49
phosphorylation of Cytc. Characterization of this specific PTM can demonstrate the
overall regulation of Cytc in human tissue types that contain the modification, specifically
in the context of respiration and apoptosis. To complete this objective, we will use an in
vitro model with recombinant proteins and a cell culture model. Thereby, we proposed
two aims:
Specific Aim I: Determine the functional characteristics of Cytc at T49 in vitro using
purified recombinant proteins.
Specific Aim II: Determine the functional characteristics of Cytc at T49 using a cell-based
model.
To study the functional effects of Cytc phosphorylation in both of the systems
described above, a T49E phosphomimetic mutant was generated in addition to an
unphosphorylated WT and a T49A control mutant that cannot be phosphorylated at this
site. If the proposed hypothesis matches with the previous data of the phosphomimetic
Cytc variants produced in the lab for other phosphorylation sites, phosphorylation of Cytc
T49 will continue to demonstrate regulation of the electron transport chain, specifically
through controlled respiration that prevents hyperpolarization of the mitochondrial
membrane potential. The prevention of hyperpolarization contributes to lowered ROS
production and inhibition of apoptosis.
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2.1 Introduction
Cytc serves as a single electron carrier from complex III to complex IV of the
mitochondrial ETC (57). Cytc is a highly conserved protein consisting of 104 amino acids
in mammals. Like other cytochrome proteins, Cytc contains a covalently attached heme
group that is essential for the catalytic functions of the protein (57). Cytc is a crucial life
and death decision molecule in the cell (57,58). In order to promote cell death Cytc leaves
the mitochondrial intermembrane space and gets released into the cytosol where it
interacts with apoptosis protease activating factor 1 (apaf-1), which ultimately leads to the
formation of the apoptosome. Once the apoptosome is formed it activates caspase-9 and
then initiates the cell-death pathway (57-59). In addition to respiration and apoptosis, this
small 12-kDa globular protein has other multiple cellular functions. For example, Cytc is
important for supercomplex formation in the ETC (60). Cytc also functions as a cardiolipin
peroxidase. Cardiolipin is a mitochondrial lipid that binds to Cytc. Cardiolipin-bound Cytc
demonstrates a conformational change and acts as a catalyst that promotes cardiolipin
peroxidase activity in the presence of H2O2 (58,61). This will ultimately lead to the
oxidation of cardiolipin, thereby releasing Cytc from the mitochondria and initiating
apoptosis (51,58,61,62). There are few reports suggesting that Cytc can respond to DNA
damage in the nucleus by interacting with chaperones involved in nucleosome assembly
(59,63). Furthermore, Cytc has demonstrated inositol 1,4,5 triphosphate receptor binding
capabilities within the endoplasmic reticulum (ER) of the cell during apoptosis, which
causes additional calcium influx into the cytosol and mitochondria. The calcium influx into
the mitochondria causes a positive-feedback mechanism ultimately promoting more Cytc
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to be released into the cytosol and initiating apoptosis as described above (64-66).
Conversely, under normal conditions Cytc promotes cell survival through its functional
capabilities of being a reactive oxygen species (ROS) scavenger. This is done through
its ability to take up and donate electrons efficiently (49,67). Additionally, Cytc takes part
in redox-coupled protein import and the reduction of p66Shc, which is a protein that has
demonstrated ROS production and apoptotic capabilities (58,68). Conclusively, Cytc
plays an essential role in cellular life and death functions. However, to understand its
complete regulation and functional characteristics, the enzyme should be studied at the
posttranslational level, specifically through phosphorylations that are present in about 3080% of the Cytc pool (57).
Previously characterized phosphorylation sites Tyr48, Tyr97, Thr28, Ser47, and
Thr58 will be discussed. Other than phosphorylations, various PTMs of Cytc have been
established such as methylations, acetylations, and nitrations but have not been reported
to be present in a significant fraction of the Cytc pool, unlike phosphorylation (57).
Mahapatra et al. 2016, reported that Cytc is phosphorylated at threonine 28 (T28) in the
mammalian kidney. It was observed that in vivo phosphorylated kidney Cytc
demonstrated 50% less oxygen consumption compared to unphosphorylated Cytc (58).
From the initial kinetic data, it was inferred that T28 phosphorylation led to partial inhibition
of respiration, ultimately preventing hyperpolarization of the mitochondrial membrane
potential, minimizing ROS production. They further elucidated the regulation of Cytc
through T28 phosphorylation by using a phosphomimetic variant, T28E. The T28A
replacement served as a control that cannot be phosphorylated. It was determined that
T28E and T28A Cytc replacements reduced respiration rates by 73% and 51%,
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respectively (57,58). To study the role of T28 phosphorylation in apoptosis, they
measured downstream casapase-3 activity in the presence of phosphomimetic Cytc
through a cell-free apoptosis assay using cytosolic extracts from Cytc knockout
fibroblasts. The results confirmed that T28 phosphorylation doesn’t affect the apoptotic
function of Cytc (58). The rate of reduction and oxidation of T28 Cytc was determined in
the presence of ascorbate and H2O2 as the reductant and oxidant, respectively. The data
showed

that

phosphomimetic

Cytc

has

a

greater

reducing

capability

than

unphosphorylated WT and T28A Cytc, suggesting that T28E Cytc may also act as a better
ROS scavenger (58). Another proapoptotic function of Cytc is cardiolipin peroxidase
activity that facilitates the release of Cytc from the mitochondria. Cardiolipin peroxidase
activity measurements showed that phosphomimetic T28E Cytc resulted in lower
cardiolipin peroxidase activity compared to WT Cytc. However, T28A Cytc demonstrated
higher peroxidase activity than WT and the phosphomimetic, suggesting that the T28A
mutant can unfold more easily compared to the other Cytc variants (58). Finally, to study
Cytc function in intact cells that mimic more physiological conditions of mitochondria, Cytc
knockout cell lines stably overexpressing the T28 variants were generated. Importantly,
the cell line expressing phosphomimetic Cytc showed a 60% reduction in respiration,
suggesting that Cytc can regulate respiration within the ETC in intact cells. Consequently,
the mitochondrial membrane potential as well as ROS production decreased (57,58). An
online tool, Scansite, for in silico kinase predictions was used to identify the potential
kinase that phosphorylates Cytc at T28. In vitro kinase assays followed by mass
spectrometry,

pharmacological

activation/inhibition

and

co-immunoprecipitations

concluded that AMPK is the specific kinase that phosphorylates T28 Cytc (58).
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Similar experimental procedures were used to characterize S47 and T58
phosphorylations of Cytc (57,69,70). The following basal phosphorylations were mapped
out in the heart (Tyr97), kidney (Thr28), and liver (Tyr48) (57-59,69,70). S47
phosphorylation of Cytc was identified in the brain under basal conditions but the protein
was completely dephosphorylated in ischemic conditions as seen in stroke. The overall
goal of the study was to elucidate phosphorylation mechanism of S47 in brain
ischemia/reperfusion injury through ETC flux, hyperpolarization of the mitochondrial
membrane potential, and ROS production as described (57,58,69). S47 phosphorylation
leads to partial inhibition of respiration when compared to dephosphorylated Cytc purified
from ischemic brain tissue (69). In order to functionally characterize S47 phosphorylation,
a phosphomimetic variant, S47E Cytc, was generated along with S47A Cytc as a control.
Cytc residue S47 interacts with COX subunit VIIa based on a computational docking
model (71). Therefore, the differences in brain and heart isoforms of COX were accounted
for when determining COX activity (69,72). In the presence of the phosphomimetic Cytc,
cellular respiration showed a 54% decrease compared to WT, similar to the in vivo
phosphorylated protein suggesting that S47E is a good phosphomimetic model (69). Both
S47E and S47A variants demonstrated inhibitory effects of their respective proapoptotic
capabilities when compared to WT Cytc (58,69). It was suggested that the hydroxyl
functional group on S47 is crucial for apoptosome formation and that S47 phosphorylation
hinders Apaf-1 interaction. Again, cardiolipin peroxidase activity was measured to further
study the proapoptotic behavior of Cytc. Both S47E and S47A demonstrated lower
peroxidase activity compared to WT Cytc, further supporting the anti-apoptotic functions
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of S47 modified Cytc (69). The same anti-apoptotic behavior demonstrated above was
observed for T58 phosphorylation of Cytc (70). Recently, Wan et al, generated a T58E
phosphomimetic Cytc to study this phosphorylation. T58 phosphorylation was primarily
identified in rat kidney. Additionally, a T58A variant (non-phosphorylatable) and a T58I
variant were generated. The isoleucine replacement was generated because the T58
residue is replaced by an isoleucine residue in humans (70). The T58E, T58A, and T58I
variants demonstrated reduced caspase-3 activity by approximately 70, 50, and 60%,
respectively, compared to WT Cytc. This suggested that the mutant forms inhibit
apoptosome formation and other proapoptotic capabilities, again, potentially due to the
importance of the hydroxyl group of the threonine at this site (69,70). Additionally, intact
cellular respiration decreased in the mutants comparable to the results of all
phosphomimetic mutants generated. This gives further insight and conclusive evidence
that phosphorylation leads to partial inhibition of the ETC, ultimately preventing
hyperpolarization of the mitochondrial membrane potential and ROS production
(57,58,69,70). Additionally, they investigated the redox potential, rate of reduction and
rate of oxidation of the Cytc variants. The phosphomimetic Cytc exhibited lower redox
potential rates as well as lower oxidation and higher reduction rates (70). The midpoint
redox potentials demonstrated similar ranges among each of the variants, which
suggested that it plays a minor role if any in understanding their functional effects.
However, the lower oxidation rate and higher reduction rate of the phosphomimetic may
induce controlled respiration and increase ROS scavenging capabilities (70). When the
phosphomimetic was subjected to high concentrations of H2O2 under both reduced and
oxidized states, increased resistance to heme degradation was observed, which may
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have been caused by a conformational change in the protein leading to a lower oxidation
rate (70).
As described from the literature presented above, Cytc phosphorylation is
essential to understand regulation of this multifunctional protein. Only a few recent
publications have been discussed thoroughly. The initial studies of Tyr48 and Tyr97
phosphorylations gave insightful knowledge to further study Cytc and its mechanistic
regulation through experimentation of different disease states and tissues (27,59).
Tyr48 and Tyr97 phosphorylations were found in bovine liver and heart Cytc,
respectively. Tyr48 was the first mapped phosphorylation site from bovine liver. It was
demonstrated that this modification completely abolished caspase-3 activity, suggesting
it needs to meet the needs of the liver as it is the organ that carries out detoxification in
the body. Additionally, Tyr48 resulted in lower levels of CL peroxidase activity and COX
activity (57,73,74). Tyr97 phosphorylation demonstrated sigmoidal kinetics during COX
analysis, which is different when compared to the reaction with non-phosphorylated Cytc
and COX as that reaction showed hyperbolic kinetics. This suggested that
phosphorylation inhibits the reaction with COX and affects enzyme functionality.
Additionally, Tyr97 did not demonstrate abolished caspase-3 activity, which is an opposite
result of Tyr48 (57). Both of these modifications suggest the regulatory importance of Cytc
through phosphorylation.
Thoughtful attention was given to understand the regulatory functional effects of
Cytc. Through the experimental design established in the Hüttemann lab, the goal of this
project was to characterize the functional effects of T49 Cytc through the generation of a
phosphomimetic mutant, T49E Cytc. Ultimately, the characterization of this specific PTM

20
can lead to a better understanding of its effect when present in human tissue under basal
conditions or in potential disease states such as cancer.
2.2 Materials and Methods
2.2.1 Cytochrome c from bovine heart tissue
Cow (bovine) heart cytochrome c was commercially obtained from Sigma-Aldrich.
2.2.2 Mass spectrometric analysis to identify post-translational modifications
Phosphorylation site mapping on the commercially obtained bovine Cytc protein was
performed as described (27). The purified Cytc was digested with trypsin and subjected
to titanium dioxide (TiO2) for phosphopeptide enrichment. Following, the sample was
desalted with a Sep-Pak C18 reverse phase chromatography as described in (75) and
dried in a Speed Vac plus (Thermo Savant, Holbrook, NY). The peptides obtained were
then injected and analyzed by electrospray ionization mass spectrometry (LTQ OrbitrapVelos, Thermo Scientific, Waltham, MA). Each peak obtained from the MS/MS spectrum
were assigned to peptide sequences through the UniProt protein database. The Mascot
algorithm was used to search for any post-translational modifications. Phosphorylated
peptide spectra were then manually verified.
2.2.3 Mutagenesis of recombinant Cytochrome c
Rodent somatic Cytc cDNA was cloned into the pLW01 expression vector plasmid (gifted
from Dr. Lucy Waskell, University of Michigan) (74,76). This expression plasmid also
encodes for a heme lyase, CYC3, which is an enzyme absent in bacteria, but necessary
for the covalent attachment of the heme group to apo-Cytc. A phosphomimetic
replacement was generated by conducting site-directed mutagenesis of the T49 residue
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of rodent WT Cytc to a negatively charged glutamate residue (T49E). The utilization of a
phosphomimetic at this site has proven to be advantageous as it allows to functionally
mimic

the

effects

of

phosphorylation

of

the

protein

(74).

Additionally,

an

unphosphorylatable control was generated at T49 using the uncharged alanine residue
(T49A). The T49 replacements were generated through the QuickChange lightning sitedirected mutagenesis kit (Agilent, Santa Clara, CA) using the protocol provided by the
manufacturer. The pLW01 Cytc expression plasmid was amplified using the following
mutagenesis primers. Forward primers 5’-GGATTCTCTTACGCGGATGCCAACAAG- 3’
(Tm = 61°C) and 5’-GGATTCTCTTACGAAGATGCCAACAAG-3’ (Tm = 58°C) and the
corresponding reverse primers 5’-CTTGTTGGCATCCGCGTAAGAGAATCC-3’ (Tm =
61°C) and 5’-CTTGTTGGCATCTTCGTAAGAGAATCC- 3’ (Tm = 58°C) were used for the
mutagenesis PCR to generate the T49A and T49E replacements, respectively, as
described (74). DpnI restriction enzyme was used to digest the parental DNA, which
allowed the mutated DNA to be transformed into XL10-Gold Ultracompetent cells
(Stratagene, Technologies, La Jolla, CA). Following transformation, individual colonies of
pLW01 mutant Cytc plasmids were purified using a Wizard Plus SV miniprep purification
system (Promega, Madison, WI). The purified samples were then sent in for sequencing
to confirm that the mutagenesis was successful (Genewiz, South Plainfield, NJ).
2.2.4 Expression and purification of recombinant Cytochrome c replacements
Following sequence confirmation, the mutant plasmids were transformed into competent
E. coli C41 (DE3) cells (Lucigen, Middleton, WI) for recombinant protein expression (74).
To allow for high-volume protein expression, the replacements were then cultured in 10
mL of Lysogeny Broth (LB) and 100 mg/mL of ampicillin. These small cultures were
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allowed to grow overnight at 37°C in a shaker at 240 rpm. After 14 to 18 hours of
incubation, the cultures were added to 1 L of Terrific Broth (TB) media supplemented with
100 mg/mL carbenicillin and incubated as described above until the cultures reached an
optical density (A600) of 0.8 to 1.2 (approximately 5 hours). One hundred μM isopropyl βD-1-thiogalactopyranoside (IPTG) was used to induce the expression of Cytc and
overexpression was completed following 2 to 6 hours of incubation at 37°C. Protein
overexpression was confirmed by the presence of a pink bacterial pellet, a characteristic
color of Cytc due to its covalently attached heme group. One liter centrifugation bottles
were used to harvest the bacterial cells using a SLC-6000 centrifugation rotor at 8,400 x
g at 4°C for 40 minutes. The Cytc pellets were extracted, resuspended in 20 mM
phosphate buffer at pH 7.4 and supplemented with 0.2 mM protease inhibitor
phenylmethylsulfonyl fluoride (PMSF). Initial lysis of the pellets was conducted with a
Branson Sonifier W-350 cell disrupter (Branson Sonic Power Co.) and sonicated twice at
output control 5. Bacterial cells were further lysed using a French pressure cell press
(AMINCO, American Instrument CO.). The lysates obtained were centrifuged at 20,000 g
at 4°C for 45 minutes. The supernatant obtained was adjusted to pH 7.4 and ion exchange
chromatography was conducted for purification as described previously (74). A
diethylaminoethyl (DEAE) and carboxymethyl (CM) purification system was used to
obtain the Cytc fractions, respectively. DEAE is a positively charged resin that binds
negatively charged proteins that can be released from the column through increasing
buffer salt concentrations. Contrariwise, CM is a negatively charged resin that binds
positively charged proteins that can also be released by increasing buffer salt
concentrations. The DEAE column was equilibrated with 20 mM potassium phosphate
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buffer (KPi) at pH 7.4 and conductivity at 3 ms/cm. The CM column was equilibrated with
30 mM KPi at pH 6.5 with the conductivity at 5 ms/cm. Cytc flow-through was collected
and adjusted with respective to each column (i.e., pH to 6.5 when ran through CM
column).
2.2.5 Concentration determination of Cytochrome c
The purified recombinant WT Cytc and T49 replacements were first fully reduced using
100 mM sodium dithionite (Na2S2O4) and desalted using a NAP-5 column (GE
Healthcare, Piscataway, NJ). The absorbance at 550 nm was measured using a Jasco
V-570 double beam spectrophotometer (2-nm bandwidth). To determine concentration,
the absorbance at 550 nm of the oxidized form was subtracted from the reduced form of
Cytc using the mathematical equation: (Abs550reduced- Abs550oxidized) /19.6mM x dilution
factor. Following concentration determination, a 10% Tris-Tricine SDS-PAGE gel with
Coomassie blue staining was done to determine if Cytc purification was successful.
2.2.6 Stable cell line expression of Cytochrome c replacements
T49 Cytc variants were expressed in Cytc double knockout mouse lung fibroblast cells.
The pBABE-puromycin mammalian expression vector plasmid (Addgene, Cambridge,
MA) was used with rodent Cytc. The same primers previously described above were used
and site-directed mutagenesis was conducted. C-terminal 1 x FLAG-tagged WT, T49A,
and T49E Cytc mutants were generated. The phosphomimetic and unphosphorylatable
control were then transfected into Cytc double knockout mouse lung fibroblast cells. The
transfected cells were cultured in DMEM supplemented with 10% FBS, 1%
Penicillin/Streptomycin, 50 µg/ml uridine, 1 mM pyruvate at 37°C in 5% CO2. Stable
expression of the T49 Cytc variants was determined using western blotting analysis.
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2.2.7 Gel electrophoresis and western blotting analysis of Cytochrome c variants
A sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) gel was
run to confirm equal expression among the T49 Cytc variants after culturing for 2 to 3
weeks. The cells were harvested by trypsinization and lysed in RIPA lysis buffer. The
samples were then centrifuged, and the supernatant was extracted as the cell lysate.
Protein concentration was determined using a Lowry assay protein kit (Bio-Rad) and 200
ng of total protein was used for the western blotting analysis. After running the cell lysates
on a 10% Tris-Tricine gel, the proteins were transferred to a PVDF membrane (0.2 µm,
Bio-Rad, Hercules, CA) using a semi-dry transfer apparatus in 25 mM Tris base, 192 mM
glycine and 20% methanol transfer buffer for 30 min at 90 mA. The blots were probed
using a 1:5000 dilution of mouse anti-Cytc primary antibody (556433, 7H8.2C12, BD
Biosciences, San Jose, CA). This was followed by a 1:10,000 dilution of anti-mouse IgG
horseradish secondary antibody (NA93IV, GE Healthcare, Chicago, IL). Signals were
detected on film using Amersham ECL prime western blotting reagent (GE Healthcare).
2.2.8 Measurement of Cytochrome c reduction and oxidation rates
Oxidation and reduction rates of T49 Cytc variants were measured using hydrogen
peroxide (H2O2) and ascorbate, respectively. These kinetic parameters were determined
spectrophotometrically as described (48). To measure the rate of oxidation of Cytc with
H2O2, WT and T49 Cytc variants were fully reduced using 100 mM Na2S2O4 and desalted
using a NAP-5 column (GE Healthcare, Piscataway, NJ). H2O2 (100 μM) was quickly
added to the reaction mixture that contained 15 μM reduced Cytc in 0.2 M Tris-Cl at pH
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7. After 10 s, the decrease of the 550 nm absorption peak was measured, and the
concentration of the oxidized protein was calculated as described above. In the same
manner described above, the reduction rate of Cytc was measured using 200 μM
ascorbate. First, Cytc variants were fully oxidized with K3Fe (CN)6 and desalted using the
NAP-5 columns. Ascorbate (200 μM) was quickly added to the reaction mixture of 15 μM
ferri-Cytc in 50 mM of sodium phosphate at pH 7.0. The initial change in 550 nm
absorbance was measured and the concentration of reduced Cytc was calculated as
described above.
2.2.9 Measurement of Cytochrome c superoxide scavenging capabilities
Superoxide scavenging capacity of Cytc was tested using the hypoxanthine/xanthine
oxidase reaction system. Reduction of Cytc in the presence of superoxide was measured
spectrophotometrically at 550nm. The protocol has been modified from previously
published methods used to generate superoxide within the reaction (77,78). The Cytc
variants were first fully oxidized with K3Fe(CN)6 and desalted using a NAP-5 column.
Superoxide was generated in a reaction mixture with 10 μM ferro-Cytc variants, 100 μM
hypoxanthine (H9377-Sigma), 14.2 nM catalase (C3155-Sigma), 181.5 nM xanthine
oxidase (X4500-Sigma), and 1X PBS to bring the sample to a final volume of 200 μL.
Catalase was used to quench H2O2 production. The absorbance at 550 nm was taken
every 15 sec for 3 min following the addition xanthine oxidase and the initial rate of
reduction was calculated. Superoxide dismutase (SOD; 925 nM; Sigma) was used as a
negative control to demonstrate the reaction is successfully producing superoxide, which
is rapidly degraded in the presence of SOD.
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2.2.10 Heme degradation assay
The heme group of the T49 Cytc variants was monitored spectrophotometrically to study
the structural integrity of Cytc when treated with a high concentration of H2O2 as
previously described (48). Cytc was first fully oxidized and desalted using a NAP-5
column. A high concentration of H2O2 (3 mM) was added to ferri-Cytc (5 μM) in 50 mM
KPi buffer at pH 6.1. The dissipation of the Soret band at 408 nm was analyzed and
absorbance readings were taken at 60, 200, 400, 600, and 800 s.
2.2.11 Caspase-3 activity assay
Caspase-3 activity was assayed using cytosolic extracts from Cytc-/- mouse embryonic
cell line (ATCC® CRL-2613TM, Manassas, VA), incubated with exogenous recombinant
Cytc variants. An in vitro cell-free apoptosis detection system was used, in which the
somatic Cytc is deficient as described (74). Cells were first cultured in 8 x 75 cm2 flasks,
pelleted, and washed with cold PBS followed by a single wash with cytosolic extraction
buffer (CEB: 20 mM HEPES, pH 7.5, 1.5 mM MgCl2, 10 mM KCl, 1 mM EGTA, 1 mM
EDTA, 1 mM dithiothreitol, 100 μM PMSF). To the washed cell pellet, 1 mL of CEB was
added and transferred to a 2 mL Dounce homogenizer, in which the cell suspension was
allowed to swell for 15 min on ice in the hypotonic CEB. A tight pestle was used with 3035 strokes to disrupt the cells. The lysates were centrifuged at 15,000 x g for 15 min at
4°C to remove organelles and nuclei. The DC protein assay kit (Bio-Rad, Hercules, CA)
was used to determine the total protein concentration of the cytosolic samples that were
diluted to 2 mg/mL. Reaction mixtures containing 20 ng/μL Cytc variants, cytosolic extract,
ATP and buffer were then incubated for 2.5 h at 37°C to allow apoptosome formation.
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Following incubation, 1 mM DTT and Rhodamine 110-linked DEVD tetrapeptide was used
as an artificial substrate of caspase-3, which fluoresces upon cleavage by caspase-3.
Fluorescence was measured using a Fluoroskan Ascent FL plate reader (Labsystems,
Thermo Scientific, Waltham, MA) and was measured for 2 hours at 30 min intervals. The
excitation absorbance filter was at 485 nm/14 nm bandwidth and emission filter was at
527 nm/10nm bandwidth. A caspase-3 inhibitor was used as a control and was subtracted
from the values obtained along with the background in the absence of exogenous Cytc.
The cleaved artificial substrate was calculated and expressed as a change in percentage
compared to WT.
2.2.12 Cardiolipin peroxidase activity assay
Cardiolipin peroxidase activity was analyzed by measuring the fluorescence of resorufin,
which is the oxidation product of Amplex red. Liposomes containing 0%, 20%, 30%, and
50% of tetraoleoyl-cardiolipin (TOCL) and 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC) were generated in 20 mM K-HEPES buffer, at pH 7.2. The liposomes were
prepared by sonication on ice for 30 s, repeated 5 times. A 96-well plate was used in
order to incubate 25 μM liposomes with 1 μM Cytc in the presence of 20 mM K-HEPES.
A 10 min incubation period followed the addition of Cytc to the plates to allow successful
binding between Cytc and cardiolipin. Resorufin fluorescence was measured using a
Flouroskan Ascent microplate reader at excitation and emission wavelengths of 530 nm
and 590 nm, respectively. The rate of the reaction was measured directly after the addition
10 µM Amplex Red and 5 µM H2O2 for 5 min. The fluorescence reaction rate was
measured as a liner function over time span where the units reported were fluorescence
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(AU) per min. This experiment was adapted as previously described with the
modifications demonstrated above (69,70,74).
2.2.13 Measurement of Cytochrome c oxidase activity
Purified cow liver COX was diluted to 3 µM and dialyzed overnight in COX dialysis buffer
(10 mM K-HEPES, 40 mM KCl, 1% Tween 20, 10 mM KF, 2 mM EGTA, supplemented
with 0.2 mM ATP) at 4°C to remove bound cholate (58). Tetraoleyl cardiolipin (TOCL,
Sigma) was added at a 40:1 molar ratio prior to dialysis. Dialysis tubing used had a
molecular weight cut-off of 12,000-14,000 Da. Oxygen consumption was measured using
a Clark-type oxygen electrode in a closed chamber (Oxygraph system; Hansatech,
Petney, UK) in a total volume of 220 µL of COX measuring buffer. Ascorbate was used
as an electron donor for Cytc. Increasing concentrations of Cytc from 2 to 25 µM was
titrated into the oxygen chamber. The oxygen consumption data was analyzed using the
Hansatech Oxygraph software. COX activity was expressed as turnover number (sec−1)
(70).

2.2.14 Statistical analysis
Statistical analysis was conducted using the Wilcoxon rank sum test. Data are reported
as means ± standard error and were considered statistically significant (*) with p < 0.05.
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2.3 Results
2.3.1 Mass spectrometry data revealed bovine heart Cytochrome c is
phosphorylated on threonine 49
Commercially available Cytc samples from bovine heart were analyzed by mass
spectrometry. Mass spectrometric analysis revealed that Cytc is phosphorylated at
threonine 49. Figure 4 demonstrates the phosphorylation detected on Cytc and is denoted
by the Y4 and Y5 fragments.

Figure 4. Mass spectrometric analysis of Cytc from bovine heart. Nano-LC/ESI/MS/MS
data revealed a phosphorylation at residue threonine 49 in the peptide sequence above.
The phosphorylation was assigned by fragment ions y4 and y5.
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2.3.2 Overexpression and purification of recombinant Cytc variants in E. coli
Characterization of Cytc phosphorylation has been successful by replacing the
phosphorylated residue with an amino acid that mimics phosphorylation. Therefore, a
phosphomimetic, T49E, and an unphosphorylatable control, T49A, were generated as it
allows for efficient, high-volume recombinant Cytc protein expression. Additionally, the
phosphomimetic mutant is able to retain its negatively charged side chain, which remains
stable during functional assays compared to in vivo phosphorylated Cytc (74,79). The
generated replacements in the pLW01 bacterial expression plasmids were transformed
into C41(DE3) E. coli cells. The Coomassie blue-stained gel confirms the Cytc
replacements were purified to near homogeneity (Fig. 5).

Figure 5. Coomassie blue-stained gel showing the purity of the overexpressed
recombinant Cytc replacements against WT and commercially purchased Sigma Cytc. As
shown above, the recombinant protein replacements were purified as shown on the 10%
Tris-Tricine SDS-PAGE gel.
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2.3.3 Western blot analysis showed Cytc knockout cell lines stably transfected with
Cytc
To begin experiments of Specific Aim II, Cytc variants were expressed in Cytc double
knockout mouse lung fibroblast cells. Stable cell line clones that demonstrated equal Cytc
expression were selected. Confirmation that Cytc was stably expressed at similar
expression levels was done through western blotting analysis. The cells that stably
expressed each mutant were cultured and frozen at -80°C for future functional assays.

Figure 6. Western blot analysis of the WT, T49A, T49E Cytc and empty vector (EV)
transfected cell lines is shown above. This figure demonstrates equal expression among
the variants and allowed for the selection of cell lines for future experiments.

2.3.4 Phosphomimetic Cytc demonstrates an increased rate of reduction
Rate of reduction and oxidation experiments were conducted on T49 variants to
understand any changes in the ability of Cytc to function as a ROS scavenger in the
presence of these substitutions. Shown below are the kinetics of the rate of reduction
where 15 µM samples of Cytc were prepared. First, the samples were oxidized using
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potassium ferricyanide and run through a NAP5 column to remove the oxidant. Using the
fixed wavelength program on the spectrophotometer, 550 and 630 nm absorbance
readings were measured. The 550 nm wavelength was used as it is the characteristic
alpha peak of reduced Cytc. The 630 nm was taken as a background. For the rate of
reduction measurements, ascorbate was used as the reductant and wavelength
measurements were taken at 10, 20, and 30 s. In the presence of ascorbate, the
phosphomimetic Cytc variant demonstrated a higher rate of reduction compared to the
WT as shown below. T49A and T49E demonstrated an approximate 76% and 79%
increased reduction rate, respectively, compared to WT (Figure 7).

Figure 7. The rate of reduction of the recombinant Cytc replacements in the presence of
ascorbate is shown above. Cytc variants (15 µM) were fully oxidized using potassium
ferricyanide and reduced with 200 µM ascorbate. The initial kinetic rate of reduction is
shown above. Data are expressed as means ± s.e.m. T49E Cytc shows a dramatic
increase in the reduction rate compared to WT. *, p < 0.05.
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2.3.5 Phosphomimetic Cytc demonstrates a similar rate of oxidation when
compared to WT Cytc
With the same experimental outline, rate of oxidation measurements of Cytc was
performed. Instead of using potassium ferricyanide, the Cytc variants were completely
reduced using sodium dithionite and were passed through a NAP5 column. H2O2 was
used to oxidize Cytc, and the rest of the experiment followed the same manner as
previously stated for rate of reduction. When compared to WT, rate of oxidation is slightly
lower for T49E Cytc. T49A Cytc demonstrated approximately a 15% increase in its rate
of oxidation when compared to WT. Conversely, the phosphomimetic demonstrated a 5%
decrease in its oxidation rate when compared WT. To give a proper conclusion in the
following experiments, future molecular dynamics simulations should be used to interpret
the data by showing a more open/accessible or closed structure of the protein.

Figure 8. The rate of oxidation of recombinant Cytc variants in the presence of H2O2 is
shown above. Cytc variants (15 µM) were fully reduced using sodium dithionate and
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oxidized with 100 µM H2O2. The initial kinetic rate of oxidation is demonstrated above.
Data were expressed as means ± s.e.m. T49E Cytc shows a similar rate of oxidation
when compared to WT.

2.3.6 Superoxide scavenging is reduced in phosphomimetic Cytc
The kinetics of the reduction Cytc rate by superoxide was further elucidated through an
experiment to understand the role of Cytc as a ROS scavenger. Superoxide is the
predominant form of ROS in the mitochondria. The Cytc variants were completely
oxidized using potassium ferricyanide and run through a NAP5 column to remove the
oxidant. A hypoxanthine/xanthine oxidase system was used to generate superoxide
within the cuvette. SOD was used as a negative control. The reduction rates of T49A and
T49E were dramatically decreased by 93% and 97%, respectively, when compared to
WT. The slow reduction by superoxide suggests that modifying the T49 alters the
protein’s ROS scavenging ability.
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Figure 9. The rate of reduction of the recombinant Cytc replacements in the presence of
superoxide using a hypoxanthine/xanthine oxidase system was generated above. Fully
oxidized Cytc variants (10 µM) were reduced by superoxide. The initial kinetic rate of
reduction was calculated. Data were expressed as means ± s.e.m. T49E Cytc showed a
decreased reduction rate compared to WT. *, p < 0.05.
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2.3.7 Phosphomimetic Cytc demonstrated increased susceptibility to heme
degradation by H2O2.
The Cytc variants were subjected to high levels of H2O2 to test the ability of the mutants
to resist heme degradation. This was done by measuring the absorbance at 408 nm
(Soret band of Cytc) in the presence of H2O2. The phosphomimetic variant demonstrates
increased susceptibility to heme degradation by H2O2 suggesting that the modification
cause the protein to be structurally less stable when exposed to oxidative stress.

Figure 10. The absorption of Cytc at the Soret band was measured in the presence of a
high concentration of H2O2 (3mM). Data are expressed as a percentage of decrease in
absorbance at the Soret band. Data were expressed as means ± s.e.m. T49E Cytc
showed increased susceptibility to become degraded at the heme when subjected to
H2O2 compared to WT.
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2.3.8 Phosphomimetic Cytc demonstrated decreased caspase-3 activation
The apoptotic activity of Cytc variants was measured using a caspase-3 activity assay.
Cytosolic extracts from Cytc knockout cells were prepared and incubated with Cytc
mutants to allow apoptosome formation. The caspase-3 assay kit contained an artificial
caspase-3 substrate, rhodamine 110-linked DEVD tetrapeptide, that fluoresced upon
cleavage by caspase-3 (58,69). The T49A and T49E demonstrated reduced caspase-3
activity by approximately 42% and 38%, respectively, suggesting lower levels
apoptosome formation in the presence of the mutants.

Figure 11. Caspase 3 activity was measured using cytosolic extracts of Cytc-/- mouse
embryonic fibroblasts at 1 mg/mL of total protein concentration. The extracts were
incubated with the recombinant Cytc replacements at 20 µg/mL at 37°C for 2 hr. The
fluorescence was measured following cleavage of the artificial caspase-3. Data were
calculated as a percentage of WT Cytc and expressed as means ± s.e.m. T49E Cytc
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demonstrates lower caspase-3 activity suggesting that the phosphomimetic impairs
intrinsic apoptotic activity. *, p < 0.05.

2.3.9 Phosphomimetic Cytc showed lowered cardiolipin peroxidase activity
One of the pro-apoptotic functions of Cytc is cardiolipin peroxidase activity. When Cytc
binds to CL, a structural change occurs and causes the enzyme to partially unfold,
activating it as a peroxidase. When this occurs, CL becomes peroxidized causing Cytc to
be released from the IMS (24). The peroxidase activity was analyzed using liposomes
containing 0, 20, 30 and 50% of TLCL incubated with the Cytc variants. Amplex red and
H2O2 were used to start the reaction. When the Amplex red is oxidized by peroxidized
lipids, it is converted to resorufin, which fluoresces at Ex535/Em585 nm. As the amount of
CL is increased, as shown in Figure 12, both T49A and T49E showed lower peroxidase
activity suggesting that a change at this residue may affect the conformation of the protein
and may inhibit Cytc release from the mitochondria into the cytosol, thereby limiting
apoptosis.
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Figure 12. Cytc peroxidase was measured at increasing percentages of TLCL in the
reaction. Reconstituted liposomes containing DOPC and TLCL were incubated with the
replacements. When the Amplex red reagent is oxidized by peroxidized lipids, it is
converted to resorufin, which fluoresces at Ex535/Em585 nm. Resorufin fluorescence is
reported as fluorescence (AU) per min of reaction progress. Data were expressed as
means ± s.e.m. Phosphomimetic Cytc demonstrated lower CL peroxidase activity when
compared to WT. *, p < 0.05.

2.3.10 Cytochrome c oxidase activity of T49 Cytc variants
Cytochrome c oxidase activity as a measure of oxygen consumption rate was determined
using a Clark-type oxygen electrode (60). This oxygen electrode consists of a closed
chamber that measures the rate of oxygen consumption of purified Cytc Oxidase (COX),
in the reaction with Cytc. To get reliable data and make conclusions, the experiment must
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be redone. However, preliminary data suggest that the phosphomimetic replacement
leads to controlled respiration as previously published by the lab (27,58,69,70,73).

Figure 13. COX activity was measured by titrating recombinant Cytc variants into the
oxygen chamber in the presence of cow liver COX (200 nM). COX activity data is shown
here as turnover number (sec -1).
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Chapter 3: Conclusions
3.1 Discussion
The data presented above suggests that T49 phosphorylation modulates cellular
decision-making functions of Cytc. Tissue-specific phosphorylations have been
characterized by our as described above and have been identified in kidney, brain, liver,
and heart. In the present study, it was revealed by mass spectrometric analysis that T49
phosphorylation is present in bovine heart Cytc. Based on the functional characterization
of previously mapped phosphorylation sites (Tyr97, Tyr48, Thr28, Ser47, Thr58) of the
lab, we hypothesized that T49 phosphorylation will lead to controlled respiration, optimal
intermediate mitochondrial membrane potential, lower ROS production, and inhibition of
apoptosis compared to unphosphorylated Cytc. Cytc is a central molecule in
mitochondrial respiration, which is a crucial life-sustaining function and a committing step
in apoptosis when it is released from the mitochondria. Therefore, elucidation of the
functional effects of T49 phosphorylation of Cytc is important in understanding the
regulatory mechanisms of this protein. T49 phosphorylation of Cytc has been observed
in human skeletal muscle tissue, specifically in the vastus lateralis muscle, in a
phosphoproteomics study (28). However, no functional studies have been conducted.
Based on the functional characterization of previously mapped phosphorylation sites of
the lab, specially S47 and Y48 which is adjacent to the T49 site studied here, we expected
that studies on T49 Cytc phosphorylation will establish the beneficial effects reported by
previous studies. Characterization of this specific PTM will help in the elucidation of its
effects under normal conditions and potential disease conditions.
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To study the functional effects of phosphorylation, site directed mutagenesis was used to
create two variants, a glutamine phosphomimetic replacement, T49E, as well as, a nonphosphorylatable alanine control, T49A. Recombinant Cytc replacements were
overexpressed, purified, and a series of experimental functional assays was conducted
for its functional characterization. The kinetics of Cytc reduction and oxidation rate
demonstrated that Cytc may exhibit increased ROS scavenging capabilities and a slower
electron transfer, respectively. The significantly higher reduction with ascorbate suggests
that phosphorylation at T49 may play an essential role in its ROS scavenging capabilities.
Additionally, phosphomimetic Cytc demonstrated an increased susceptibility to heme
degradation by H2O2, demonstrating oxidative stress is able to alter the function of the
protein. ROS production occurs at complexes I and III of the ETC, therefore further
elucidating the ROS scavenging capabilities of T49 Cytc may be crucial as it is
physiologically relevant for cellular life. T49A and T49E replacements both demonstrated
a drastically lower reduction rate by superoxide compared to WT Cytc. This suggests that
modifying T49 alters Cytc superoxide scavenging ability.
Additionally, Cytc plays a pivotal role in the intrinsic pathway of apoptosis by exiting the
mitochondrial IMS and interacting with cytosolic Apaf-1. Facilitation of apoptosis was
measured by examining CL peroxidase activity and caspase-3 activity in the presence of
Cytc. Liposomes with 100% DOPC, where there were was no CL present, demonstrated
high peroxidase activity which is not expected for the phosphomimetic. This could be
attributed to human error, such as using incorrect liposomes or too high of a concentration
of Cytc within the reaction mixture. Theoretically, DOPC cannot be peroxidized by Cytc.
However, as the amount of cardiolipin is increased, T49A and T49E showed lower
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peroxidase activity compared to WT suggesting that the amino acid substitution at this
residue may affect the conformation of the protein. Therefore, this may be protective as
it would lower Cytc release from the OMM into the cytosol, where apoptosis take place.
Additionally, in the caspase-3 experiment, cytosolic extracts from Cytc knockout cells
were prepared and incubated with the Cytc mutants to allow apoptosome formation.
Phosphomimetic Cytc demonstrated a decrease in caspase-3 activation suggesting lower
levels of apoptosome formation in the presence of the mutants further suggesting a
protective role for T49 phosphorylation.
COX activity was measured in a titration reaction with the recombinant replacements and
cow liver COX. Due to the difficulty of pipetting small amounts inside the chamber, large
errors occurred throughout each trial of the experiments. Unfortunately, exact conclusions
cannot be made. However, this data does suggest encouraging future results that may
align with the overall hypothesis that phosphorylation leads to controlled respiration.
Furthermore, additional functional assays must be completed, and some experiments
must be redone to fully functionally characterize Cytc phosphorylation at T49.

3.2 Future Work
First, to fully characterize the functional effects of T49 phosphorylation, cardiolipin
peroxidase activity, COX activity, and redox potential measurements of T49E
phosphomimetic Cytc should be completed using the recombinant protein system. The
redox potential is done to determine Cytc’s affinity to acquire electrons. This will complete
Specific Aim I. In Specific Aim II, the generated replacements were cloned into the pBABE
mammalian expression plasmid. Cytc knockout cell lines were transfected with the
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generated mutants and equal expression was determined as shown in Figure 6. The
overall goal of this aim was to determine the functional effects and regulatory role of T49
phosphorylation in intact cells by measuring the oxygen consumption rate, mitochondrial
membrane potential, mitochondrial ROS production, ATP production, and apoptosis as
described previously. Cellular respiration rate in intact cells will be measured using a
Seahorse bioanalyzer. Mitochondrial membrane potential will be measured using a
ratiometric probe JC-1 in phenol red-free and FBS-free medium. The JC-1 probe emits a
green fluorescence at low mitochondrial membrane potential. Conversely, at higher
mitochondrial membrane potential, JC-1 aggregates and emits red fluorescence that will
be measured using a Synergy H1 microplate reader. Mitochondrial superoxide production
will be measured using the MitoSOX probe and fluorescence will be measured using a
Synergy H1 plate reader. ATP production will be measured using the ATP
bioluminescence assay kit HS II. Apoptosis will be measured by staining with Annexin V
and propidium iodide following treatment with H2O2. Flow cytometry data will be analyzed
by the FCS Express 6 RUC software (70). The assays described above have been
established and successfully conducted by the Hüttemann lab. Therefore, completion of
these experiments is essential to obtain a fully functionally characterized protein.
Finally, a disease correlation should be further elucidated for this phosphorylation site.
The main question that must be asked is if there is a connection of this phosphorylation
with other pathologies in different tissues. Additionally, the cellular pathway that mediates
its phosphorylation and dephosphorylation must be explored. Thus, reporting a kinase
and a phosphatase that (de-)phosphorylates Cytc at T49.
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APPENDIX
Site

Modification

COX activity
with in vivo
phosphorylated
Cytc

COX activity
with
phosphomimetic
Cytc

Cell-based
Respiration

Mitochondrial
Membrane
Potential

ROS
Production

Apoptosis

Thr28

Phosphorylation

↓

↓

↓

↓

↓

↓

Ser47

Phosphorylation

↓

↓

↓

↓

↓

↓

Tyr48

Phosphorylation

↓

↓

↓

N/A

N/A

↓

Thr58

Phosphorylation

N/A

↓

↓

↓

↓

↓

Tyr97

Phosphorylation

↓

↓

↓

N/A

N/A

↓

Table 1. Demonstrated above are the functional assays conducted on each of the Cytc
variants and their respective results relative to WT Cytc. The experiments labeled N/A
are future experiments to be completed.
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Cytochrome c (Cytc) is a pivotal multifunctional mitochondrial protein that serves
as a single electron carrier between complexes III and IV of the electron transport chain.
It has important roles in both cellular respiration and apoptosis. The novel Thr49 (T49)
phosphorylation of Cytc likely affects mitochondrial respiration, membrane potential, ROS
production, ATP production, and apoptosis. Based on the functional characterization of
previously mapped phosphorylation sites (Tyr97, Tyr48, Thr28, Ser47, Thr58) of the lab,
we hypothesize that T49 phosphorylation will lead to controlled respiration, optimal
intermediate mitochondrial membrane potential, lower ROS production, and inhibition of
apoptosis compared to unphosphorylated Cytc. Here we report some of the functional
studies that aid in the functional characterization of phosphorylation of T49.
Characterization of this specific post-translational modification (PTM) can demonstrate
overall regulation of Cytc in human tissue types that contain the modification, specifically
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in the context of respiration and apoptosis. To complete this objective, we used an in vitro
model with recombinant protein and a cell culture model.
In the recombinant protein model, T49A and T49E reduction and oxidation rate
demonstrated that Cytc may exhibit a slower electron transfer rate and increased ROS
scavenging capabilities. The significantly higher reduction rate suggests that
phosphorylation at T49 may play an essential role in the ROS scavenging capabilities of
Cytc. Additionally, the phosphomimetic variant demonstrated an increased susceptibility
of heme degradation by H2O2 demonstrating oxidative stress is able to alter the function
of the protein. T49A and T49E Cytc both demonstrated a drastically lower reduction rate
by superoxide compared to WT Cytc, suggesting that modifying T49 alters Cytc’s
superoxide scavenging ability.
Further studies demonstrated Cytc’s role in apoptosis. Cardiolipin peroxidase
activity demonstrated that T49A and T49E results in lower peroxidase activity compared
to WT suggesting that the amino acid substitution at this residue may affect the
conformation of the protein. Additionally, the phosphomimetic Cytc variant demonstrated
a decrease in caspase-3 activation suggesting lower levels of apoptosome formation in
the presence of the mutants. Further experiments must be done to elucidate the functional
effects of T49 phosphorylation.
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